Thomas J. Schuetz, CHIEF EXECUTIVE OFFICER at Compass Therapeutics, Inc. (CMPX), bought 15,000 shares at $2.27 ($34K) on 2022-09-26, disclosed to the SEC on 2022-09-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CMPX | BUY | 2023-02-27 | $80K | — | Filing → |
| CMPX | BUY | 2023-02-15 | $77K | — | Filing → |
| CMPX | BUY | 2023-01-31 | $81K | — | Filing → |